Issue Date: January 8, 2018
The drug industry’s data integrity problem
As emphasis grows on managing data in pharmaceutical labs and plants—collecting and storing it, sharing it, mining it for pertinence—a basic question often goes unanswered: Is the data any good?
The quality and completeness of data associated with making drugs are, however, huge concerns at agencies such as the U.S. Food & Drug Administration. And drug companies are being forced to pay attention to data in response to a sharp increase in the number . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society